These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
631 related articles for article (PubMed ID: 34050949)
1. Biphasic anaphylaxis after exposure to the first dose of Pfizer-BioNTech COVID-19 mRNA vaccine. Abi Zeid Daou C; Natout MA; El Hadi N J Med Virol; 2021 Oct; 93(10):6027-6029. PubMed ID: 34050949 [TBL] [Abstract][Full Text] [Related]
2. COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol. Patel GB; Chhiba KD; Chen MM; Guo A; Watts MM; Cullen J; Bochner BS; Grammer LC; Greenberger PA; Saltoun CA; Stevens WW; Kuang FL; Peters AT Allergy Asthma Proc; 2021 Nov; 42(6):515-521. PubMed ID: 34871159 [No Abstract] [Full Text] [Related]
3. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020. ; MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(2):46-51. PubMed ID: 33444297 [TBL] [Abstract][Full Text] [Related]
4. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines. Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336 [TBL] [Abstract][Full Text] [Related]
5. mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach. Banerji A; Wickner PG; Saff R; Stone CA; Robinson LB; Long AA; Wolfson AR; Williams P; Khan DA; Phillips E; Blumenthal KG J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1423-1437. PubMed ID: 33388478 [TBL] [Abstract][Full Text] [Related]
7. COVID-19 vaccination including 198 patients with history of severe anaphylactic reaction - own observations. Wentrys Ł; Stopyra L Przegl Epidemiol; 2021; 75(3):315-325. PubMed ID: 35170287 [TBL] [Abstract][Full Text] [Related]
8. Biphasic anaphylaxis after first dose of messenger RNA coronavirus disease 2019 vaccine with positive polysorbate 80 skin testing result. Pitlick MM; Park MA; Gonzalez-Estrada A; Chiarella SE Ann Allergy Asthma Immunol; 2021 Oct; 127(4):498-499. PubMed ID: 34343674 [No Abstract] [Full Text] [Related]
9. Risk of Second Allergic Reaction to SARS-CoV-2 Vaccines: A Systematic Review and Meta-analysis. Chu DK; Abrams EM; Golden DBK; Blumenthal KG; Wolfson AR; Stone CA; Krantz MS; Shaker M; Greenhawt M JAMA Intern Med; 2022 Apr; 182(4):376-385. PubMed ID: 35188528 [TBL] [Abstract][Full Text] [Related]
10. Cumulative Adverse Event Reporting of Anaphylaxis After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japan: The First-Month Report. Iguchi T; Umeda H; Kojima M; Kanno Y; Tanaka Y; Kinoshita N; Sato D Drug Saf; 2021 Nov; 44(11):1209-1214. PubMed ID: 34347278 [TBL] [Abstract][Full Text] [Related]
11. Management of BNT162b2 mRNA COVID-19 vaccine in children aged 5-11 years with allergies, asthma, and immunodeficiency: consensus of the Italian Society of Pediatric Allergy and Immunology (SIAIP). Novembre E; Tosca M; Caffarelli C; Calvani M; Cardinale F; Castagnoli R; Chiappini E; Cravidi C; Del Giudice MM; Duse M; Licari A; Manti S; Martelli A; Ricci G; Pingitore G; Marseglia GL Ital J Pediatr; 2022 May; 48(1):76. PubMed ID: 35578294 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk. Shavit R; Maoz-Segal R; Iancovici-Kidon M; Offengenden I; Haj Yahia S; Machnes Maayan D; Lifshitz-Tunitsky Y; Niznik S; Frizinsky S; Deutch M; Elbaz E; Genaim H; Rahav G; Levy I; Belkin A; Regev-Yochay G; Afek A; Agmon-Levin N JAMA Netw Open; 2021 Aug; 4(8):e2122255. PubMed ID: 34463744 [TBL] [Abstract][Full Text] [Related]
13. Anaphylaxis and Related Events Following COVID-19 Vaccination: A Systematic Review. Paul P; Janjua E; AlSubaie M; Ramadorai V; Mushannen B; Vattoth AL; Khan W; Bshesh K; Nauman A; Mohammed I; Bouhali I; Khalid M; Zakaria D J Clin Pharmacol; 2022 Nov; 62(11):1335-1349. PubMed ID: 35794852 [TBL] [Abstract][Full Text] [Related]
14. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease. Beckley M; Olson AK; Portman MA JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521 [TBL] [Abstract][Full Text] [Related]
15. Are the Allergic Reactions of COVID-19 Vaccines Caused by mRNA Constructs or Nanocarriers? Immunological Insights. Selvaraj G; Kaliamurthi S; Peslherbe GH; Wei DQ Interdiscip Sci; 2021 Jun; 13(2):344-347. PubMed ID: 34021862 [TBL] [Abstract][Full Text] [Related]
16. Anaphylaxis is a rare reaction in COVID-19 vaccination. Bellomo RG; Gallenga CE; Caraffa A; Tetè G; Ronconi G; Conti P J Biol Regul Homeost Agents; 2021; 35(3):839-842. PubMed ID: 34105336 [TBL] [Abstract][Full Text] [Related]
17. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia. Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883 [TBL] [Abstract][Full Text] [Related]
18. Reporting of Allergic Reactions During Pfizer-BioNTech BNTT162B2 Vaccination in Israel. Anis E; Preis SA; Cedar N; Tal Y; Hershkowitz I; Hershko AY J Allergy Clin Immunol Pract; 2022 Nov; 10(11):2969-2976. PubMed ID: 35872216 [TBL] [Abstract][Full Text] [Related]